Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krebs Biochemicals and Industries has informed the stock exchanges that its trading window will be closed from the close of business hours on March 31, 2026, until 48 hours after the declaration of Audited Financial Results for the fourth quarter and financial year ended March 31, 2026. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015, and applies to promoters, directors, designated persons, their immediate relatives, and all connected persons covered under the company's insider trading code. The company has stated that the date of the board meeting to consider and approve the audited financial results will be communicated to the exchanges in due course.
This is a routine compliance announcement and is not expected to have any direct impact on the stock price. It signals that audited Q4 and full-year FY26 results are upcoming, which investors should watch for as they will provide key information on the company's financial performance.